Though sales for Pfizer's (NYSE: PFE ) drug Lipitor -- the highest selling drug of all time -- have been down dramatically now that the drug has gone off patent and faces generic competition, this was actually a strong year for Pfizer. It sold its infant nutrition division and is spinning out its animal health division to focus entirely on pharmaceuticals.
In the following video, health care analysts Max Macaluso and Brenton Flynn offer an overview of Pfizer and discuss what investors can expect from the company's drug portfolio and pipeline.
While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.